Free Trial

FY2027 Earnings Forecast for IperionX Issued By Roth Capital

IperionX logo with Industrials background

Key Points

  • Roth Capital has lowered its FY2027 earnings forecast for IperionX to $0.01 per share from a previous estimate of $0.02, while maintaining a Buy rating and a target price of $74.00.
  • Wall Street Zen upgraded IperionX's rating from sell to hold, with the stock currently holding an average consensus rating of Buy and an average target price of $51.00.
  • IperionX's stock has shown resilience, with a trading increase of 4.5% recently, and the company's share price fluctuated between a twelve-month low of $12.27 and a high of $52.58.
  • Interested in IperionX? Here are five stocks we like better.

IperionX Limited Sponsored ADR (NASDAQ:IPX - Free Report) - Stock analysts at Roth Capital reduced their FY2027 earnings per share (EPS) estimates for shares of IperionX in a research report issued on Wednesday, October 1st. Roth Capital analyst J. Reagor now expects that the company will earn $0.01 per share for the year, down from their prior forecast of $0.02. Roth Capital currently has a "Buy" rating and a $74.00 target price on the stock. The consensus estimate for IperionX's current full-year earnings is ($0.08) per share. Roth Capital also issued estimates for IperionX's FY2029 earnings at $0.55 EPS.

Separately, Wall Street Zen raised IperionX from a "sell" rating to a "hold" rating in a research note on Saturday, September 20th. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, IperionX presently has an average rating of "Buy" and an average target price of $51.00.

Get Our Latest Stock Analysis on IperionX

IperionX Trading Up 4.5%

Shares of IperionX stock opened at $51.56 on Thursday. The business's fifty day moving average price is $43.43 and its 200 day moving average price is $30.50. IperionX has a twelve month low of $12.27 and a twelve month high of $52.58.

Institutional Investors Weigh In On IperionX

Hedge funds have recently modified their holdings of the stock. Thomist Capital Management LP acquired a new stake in IperionX in the second quarter valued at approximately $59,384,000. Osaic Holdings Inc. boosted its stake in shares of IperionX by 7.7% during the 2nd quarter. Osaic Holdings Inc. now owns 70,325 shares of the company's stock valued at $2,215,000 after buying an additional 5,000 shares during the last quarter. Jane Street Group LLC increased its stake in shares of IperionX by 73.8% in the second quarter. Jane Street Group LLC now owns 55,558 shares of the company's stock worth $1,750,000 after buying an additional 23,591 shares during the last quarter. Bank of America Corp DE raised its holdings in IperionX by 69.0% in the second quarter. Bank of America Corp DE now owns 35,441 shares of the company's stock valued at $1,116,000 after acquiring an additional 14,467 shares in the last quarter. Finally, OLD Mission Capital LLC bought a new position in IperionX during the 1st quarter valued at $477,000. 2.76% of the stock is currently owned by hedge funds and other institutional investors.

About IperionX

(Get Free Report)

IperionX's mission is to be the leading developer of low carbon, sustainable, critical material supply chains focused on advanced industries including space, aerospace, electric vehicles and 3D printing. IperionX's breakthrough titanium technologies have demonstrated the potential to produce titanium products that are sustainable, 100% recyclable, have low carbon intensity and to do so at product qualities that meet or exceed current industry standards.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IperionX Right Now?

Before you consider IperionX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.

While IperionX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.